Luncheon Symposia Series

Complimentary lunch provided by ARRS for up to 200

Monday, April 23, 12:15–1:15 pm

An Update of the Risks and Benefits of Gadolinium-Based Contrast Agents 


Faculty: Jeffrey Maki, MD, PhD and Howard A. Rowley, MD 

This lunch symposium will include an up to date review of the risks and benefits of Gadolinium-Based Contrast Agents.

Up to 1 CME credit available through Northwest Imaging Forums, Inc.

For information regarding registering or claiming credit, please contact:

Tuesday, April 24, 12:15–1:15 pm

A Review of the Safety of Gadolinium-Based Contrast Agents in Pediatric Imaging


FACULTY: Shannon G. Farmakis, MD

Contrast-enhanced MRI has become an increasingly utilized imaging modality in the pediatric population.  Familiarity with the safety profiles of the various gadolinium-based contrast agents (GBCAs) and approved indications is important in managing this group of patients.  The unique pharmacologic and imaging characteristics of certain GBCAs may have a role in agent selection.    

A number of recent studies in the adult and pediatric literature have described areas of high signal intensity in the globus pallidus and dentate nucleus in patients with a history of multiple prior exposures to GBCAs, and some studies have found gadolinium in tissue specimens of these areas.  There is a growing concern about the implications of these findings of gadolinium deposition by various governing bodies, regulatory authorities, physicians, and patient groups.

While currently there is no direct evidence that links gadolinium deposition with specific symptoms or syndromes, further research into the safety of the various types of agents (linear versus macrocyclic) is warranted and is supported by the American College of Radiology.  There are also implications for changes in practice, such as reporting cumulative gadolinium dosages in reports.  

Up to 1 CME credit available.

For information regarding registering or claiming credit contact please email or visit

Wednesday, April 25, 12:15–1:15 pm

Enabling Precision Health with Artificial Intelligence: Technology, Data, Use Cases, and Opportunities


FACULTY: Charles E Kahn Jr., MD, MS, FACR; Abdul Hamid Halabi, MBA; Eliot Siegel, MD; Avinash (Gopal) Avinash, MD

We are on the brink of an amazing transformation in how we approach healthcare. Precision health relies on radical advancements in advanced tools and technology, including AI. As AI technology and application adoption advances, new medical imaging use cases will emerge. Use cases drive innovative business models, value chains, and strategic decisions.  This panel of leading experts and GE Healthcare’s AI technology leader share their perspective–from point of care to reading room–on what the most prominent and powerful medical imaging use cases are, what is possible in technology, and what some of the key upcoming changes, paradigm shifts and their implications are as we head into this exciting new frontier.

This Symposium does not offer CME. 

Thursday, April 26, 12:15–1:15 pm

Achieving Early and Accurate Diagnosis of Interstitial Lung Disease


FACULTY: David J. Lederer, MD, MS; Jonathan G. Goldin, MD, PhD

Early recognition of disease symptoms and accurate diagnosis are critical to the optimal management of interstitial lung diseases (ILDs), particularly idiopathic pulmonary fibrosis (IPF), which is the most common ILD. High-resolution computed tomography (HRCT) is an essential component of the diagnostic pathway in IPF. Familiarity with the typical appearances of usual interstitial pneumonia (UIP) on HRCT is important, as it is often sufficient for establishing a confident diagnosis of IPF without the need for surgical biopsy. However, due to the heterogeneity of presentations of IPF, a radiological diagnosis of IPF using HRCT is not always straightforward, and the disease may have both typical and atypical appearances. In this regard, honeycombing—a common feature of IPF seen on HRCT—is crucial for an accurate diagnosis. Unfortunately, identification of honeycombing is often subjective, and there is some disagreement regarding its imaging features.

Join us for a lunch symposium where experts will share tips and tricks for differentiating the radiologic pattern of UIP from other idiopathic interstitial pneumonias. Illustrative cases will detail best practices for accurate interpretation of HRCT imaging and will be paired with analysis of the latest evidence on monitoring of treatment response of key clinical concepts to practice.

Up to 1 CME credit available.

For information regarding registering or claiming credit contact PeerView at 1.877.833.6141 or, or visit



The Institute for Advanced Medical Education (IAME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Institute for Advanced Medical Education (IAME) designates this enduring material for a maximum of 1 AMA/PRA Category 1 CME Credit.™. Physicians should only claim credit commensurate with the extent of their participation in the activity.